(Q39689835)

14 September 2017

1 reference

title

Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring (English)

1 reference

14 September 2017

1 reference

1 reference

Vine W

1

1 reference

14 September 2017

Bowers LD

series ordinal

2

1 reference

14 September 2017

publication date

1 January 1987

1 reference

Critical Reviews in Clinical Laboratory Sciences

14 September 2017

published in

1 reference

14 September 2017

volume

25

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

275-311

1 reference

Cyclosporin A in patients receiving renal allografts from cadaver donors

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

The structure of cyclosporin c (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Interaction of cyclosporin A with human lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

The clearance of cyclosporine by hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporine kinetics in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Pharmacokinetic study of cyclosporin A (Sandimmun) in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Interaction of cyclosporin A with antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

The effects of cyclosporin A on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporine: a new immunosuppressive agent for organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Action and toxicity of cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Complications of cyclosporin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporin A hepatotoxicity in 66 renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Venous thrombosis and cyclosporin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408368709105886

10.3109/10408368709105886

21 January 2018

Identifiers

DOI

0 references

1 reference